Vaxil Bio (TSXV:VXL) Interest Expense : C$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vaxil Bio's interest expense for the three months ended in Dec. 2023 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vaxil Bio's Operating Income for the three months ended in Dec. 2023 was C$ 0.03 Mil. Vaxil Bio's Interest Expense for the three months ended in Dec. 2023 was C$ 0.00 Mil. Vaxil Bio has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Vaxil Bio Interest Expense Historical Data

The historical data trend for Vaxil Bio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Interest Expense Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.01

Vaxil Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Vaxil Bio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Vaxil Bio (TSXV:VXL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vaxil Bio's Interest Expense for the three months ended in Dec. 2023 was C$0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was C$0.03 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was C$0.00 Mil.

Vaxil Bio's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Vaxil Bio had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Vaxil Bio Ltd has no debt.

Vaxil Bio (TSXV:VXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

VXLLF:USA

Address

C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Vaxil Bio (TSXV:VXL) Headlines

No Headlines